Oncoinvent publishes phase 1 ovarian cancer results
Lower doses of immunotherapy for skin cancer give better results
New RNA class discovered
Base to Base biotech podcast 38: Obesity, life sciences in the Netherlands, and killing cancer cells
Elix provides AI drug discovery platform to Eisai
Johnson & Johnson receives Priority Review for high-risk non-muscle invasive bladder cancer treatment
Bakar Labs to build new R&D facility for biotechs
Sanofi to acquire vaccine biotech Vicebio for $1.6bn
Elix and LINC combine on new drug discovery platform
FDA grants orphan drug designation to gene therapy for ALS
Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance
Arcus Biosciences receives Orphan Drug Designation for pancreatic cancer treatment